Amyloid-β impairs development of neuronal progenitor cells by oxidative mechanisms

Neurobiology of Aging

Volumn 27, Issue 9, 2006, Pages 1181-1192

  Mazur Kolecka, B ^a   Golabek, A ^a   Nowicki, K ^a   Flory, M ^a   Frackowiak, J ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Amyloid ; Cell culture; Neuronal progenitor cells; Neuroreplacement therapy; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN[1-40]; ANTIOXIDANT; CARBONYL DERIVATIVE; LIPID; MONOMER; OLIGOMER;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MOLECULAR MECHANICS; MORPHOMETRICS; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE GROWTH; NERVE TRANSPLANTATION; NEURAL STEM CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; ANTIOXIDANTS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHOSPHOPYRUVATE HYDRATASE; STEM CELLS; VITAMIN E;

EID: 33745999815     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.07.006     Document Type: Article

References (53)

1. Anderson S.A., Martin O., Horn C., Jennings K., and Rubenstein J.L. Distinct cortical migrations from the medial and lateral ganglionic eminences. Development 128 (2001) 353-363
2. Bacon Moore A.S., Paulsen J.S., and Murphy C. A test of odor fluency in patients with Alzheimer's disease and Huntington's disease. J Clin Exp Neuropsychol 21 (1999) 341-351
3. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82 (1991) 239-259
4. Butterfield A.D., Castegna A., Lauderback C.M., and Drake J. Evidence the amyloid-beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23 (2002) 655-664
5. Calingasan N.Y., Uchida K., and Gibson G.E. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72 (1999) 751-756
6. Cao Q., Benton R.L., and Whittemore S.R. Stem cell repair of central nervous system injury. J Neurosci Res 8 (2002) 501-510
7. Christen-Zaech S., Krafsik R., Pillevuit O., Kiraly M., Martins R., Khalili K., et al. Can J Neurol Sci 30 (2003) 20-25
8. Frackowiak J., Mazur-Kolecka B., Wisniewski H.M., Potempska A., Carrol R.T., Emmerling M.R., et al. Secretion and accumulation of Alzheimer's β-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res 676 (1995) 225-230
9. Frackowiak J., Miller D.L., Potempska A., Sukontasup T., and Mazur-Kolecka B. Secretion and accumulation of Aβ by brain vascular smooth muscle cells from AβPP-Swedish transgenic mice. J Neuropathol Exp Neurol 62 (2003) 685-696
10. Frackowiak J., Sukontasup S., Potempska A., and Mazur-Kolecka B. Lysosomal deposition of Aβ in cultures of brain vascular smooth muscle cells is enhanced by iron. Brain Res 1002 (2004) 65-67
11. Fricker R.A., Carpenter M.K., Winkler C., Greco C., Gates M.A., and Bjorklund A. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci 19 (1999) 5990-6005
12. Gage F.H. Mammalian neuronal stem cells. Science 287 (2000) 1433-1438
13. Gage F.H., Coates P.W., Palmer T.D., Kuhn H.G., Fisher L.J., Suhonen J.O., et al. Survival and differentiation of adult neural progenitor cells transplanted to the adult brain. Proc Natl Acad Sci USA 92 (1995) 11879-11883
14. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., et al. Intraneuronal Abeta 42 accumulation in human brain. Am J Pathol 156 (2000) 15-20
15. Gylys K.H., Fein J.A., Tan A.M., and Cole G.M. Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-β protein into synaptic terminals. J Neurochem 84 (2003) 1442-1451
16. Haughey N.J., Liu D., Nath A., Borchard A.C., and Mattson M.P. Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease. Neuromol Med 1 2 (2002) 125-135
17. Haughey N.J., Nath A., Chan S.L., Borchard A.C., Rao M.S., and Mattson M.P. Disruption of neurogenesis by amyloid β-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem 83 (2002) 1509-1524
18. Hemdal P., Corwin J., and Oster H. Olfactory identification deficits in Down's syndrome and idiopathic mental retagdation. Neuropsychologia 31 (1993) 977-984
19. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA 91 (1994) 1270-1274
20. Huang X., Cuajungco M.P., Atwood C.S., Moir R.D., Tanzi R.E., and Bush A.I. Alzheimer's disease, beta-amyloid protein and zinc. J Nutr 130 (2000) 1488S-1492S
21. Jankovski A., Garcia C., Soriano E., and Sotelo C. Proliferation, migration and differentiation of neuronal progenitor cells in the adult mouse subventricular zone surgically separated from its olfactory bulb. Eur J Neurosci 10 (1998) 3853-3868
22. Jin K., Peel A.L., Mao X.o., Cottrell B.A., Henshall D.C., and Greenberg D.A. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 101 (2004) 343-347
23. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
24. Khoury El.J., Hickman S.E., Thomas Ch.A., Cao L., Silverstein S.C., and Loike J.D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382 (1996) 716-719
25. Klein W.L. Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 41 (2002) 345-352
26. Kovacs T., Cairns N.J., and Lantos P.L. Olfactory centers in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport 12 (2001) 285-288
27. Lopez-Toledano M.A., and Shelanski M.L. Neurogenic effect of β-amyloid peptide in the development of neural stem cells. J Neuroimmunol 24 (2004) 5439-5444
28. Lorenzo A., and Yankner B.A. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 91 (1994) 12243-12247
29. Luskin M.B. Neuroblast of the post-natal mammalian forebrain: their phenotype and fate. J Neurobiol 36 (1998) 221-233
30. Markesbery W.R., and Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19 (1998) 33-36
31. Mattson M.P. Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy. Exp Gerontol 35 (2000) 489-502
32. Mazur-Kolecka B., Frackowiak J., Kowal D., Krzeslowska J., and Dickson D. Oxidative protein damage in cells engaged in β-amyloidosis is related to apoE genotype. Neuroreport 13 (2002) 465-468
33. Mazur-Kolecka B., Frackowiak J., Le Vine H., Haske T., Evans L., Krzeslowska J., et al. TGF-β1 enhances formation of cellular Aβ/apoE deposits in vascular myocytes. Neurobiol Aging 24 (2003) 355-364
34. Mazur-Kolecka B., Kowal D., Sukontasup T., Dickson D., and Frackowiak J. The effect of oxidative stress on accumulation of apolipoprotein E3 and E4 in a cell culture model of β-amyloid angiopathy (CAA). Brain Res 983 (2003) 48-57
35. Mazur-Kolecka B., Kowal D., Sukontasup T., Dickson D., and Frackowiak J. The effect of oxidative stress on amyloid precursor protein processing in cells engaged in β-amyloidosis is related to apolipoprotein E genotype. Acta Neuropathol 108 (2004) 287-294
36. McKeown D.A., Doty R.L., Perl D.P., Frye R.E., Simms I., and Mester A. Olfactory function in young adolescent with Down's syndrome. J Neurol Neurosurg Psych 61 (1996) 412-414
37. Murphy C. Loss of olfactory function in dementing disease. Physiol Behav 66 (1999) 177-182
38. Murphy C., and Jinich S. Olfactory dysfunction in Down's syndrome. Neurobiol Aging 17 (1996) 631-637
39. Nijjar R.K., and Murphy C. Olfactory impairment increases as a function of age in persons with Down syndrome. Neurobiol Aging 23 (2002) 65-73
40. Pike Ch.J., Burdick D., Walencewicz A.J., Glabe Ch.G., and Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13 (1993) 1676-1687
41. Potempska A., Mack K., Mehta P., Kim K.S., and Miller D.L. Quantitation of sub-femtomole amount of Alzheimer amyloid peptodes. Amyloid 6 (1999) 14-21
42. Qian X., Shen Q., Goderie S.K., He W., Capela A., Davis A.A., et al. Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron 28 (2000) 69-80
43. Sakuma K., Nakashima K., and Takahashi K. Olfactory evoked potentials in Parkinson's disease Alzheimer's disease and anosomic patients. Psych Clin Neurosci 50 (1996) 35-40
44. Serby M. Olfaction and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psych 10 (1986) 579-586
45. Sugaya K., and Brannen C.L. Stem cell strategies for neuroreplacement therapy in Alzheimer's disease. Med Hypothesis 57 (2001) 697-700
46. Talamo B.R., Rudel R.A., Kosik K.S., Lee V., Neff S., Adelman L., et al. Pathological changes in olfactory neurons in patients with Alzheimer's disease. Nature 337 (1989) 736-739
47. Temple S., and Alvarez-Buylla A. Stem cells in the adult mammalian central nervous sysytem. Curr Opin Neurobiol 9 (1999) 135-141
48. Veurink G., Fuller S.J., Atwood C.S., and Martins R.N. Rev Ann Hum Biol 30 (2003) 639-667
49. Vicario-Abejon C., Cunningham M.G., and McKay R.D. Cerebellar precursors transplanted to the neonatal dentate gyrus express features characteristic of hippocampal neurons. Neuron 15 (1995) 105-114
50. Wetter S., and Murphy C. Individuals with Down's syndrome demonstrate abnormal olfactory event-related potentials. Clin Neurophysiol 110 (1999) 1563-1569
51. Wisniewski H.M., Wegiel J., and Popovitch E.R. Age-associated development of diffuse and thioflavin S-positive plaques in Down syndrome. Dev Brain Dysfunct (1994) 330-339
52. Zigova T., Betarbet R., Soteres B.J., Brock S., Bakay R.A., and Luskin M.B. A comparision of the patterns of migration and the distribution of homotopically transplanted neonatal subventricular zone cells and heterotopically transplanted ventricular zone cells. Dev Biol 173 (1996) 459-474
53. Zucco G.M., and Negrin N.S. Olfactory deficits in Down subjects: a link with Alzheimer disease. Percept Mot Skills 78 (1994) 627-631